Method, device, equipment and storage medium for dispensing drugs to subjects in clinical trials
By determining tasks for designated visit data binding schemes for clinical trials, the relationship between visits and protocol determination tasks is formed, and the problems of inefficient drug distribution efficiency and manual recording errors in clinical trials are solved, and the efficiency and science of the trial are improved. sex.
Patent Information
- Application Number
- CN202111676975.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-12-31
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2041-12-31
AI Technical Summary
In clinical trials, subjects have problems such as inefficient drug distribution and manual recording are prone to errors, which makes the trial difficult and makes it difficult to achieve efficient drug management and treatment plan adjustments.
By determining tasks for the designated visit data binding scheme, the association between the visit and the plan determination task is formed, and the triggering plan determination task is performed during the designated visit, ensuring the accurate distribution of treatment plans and reducing the possibility of manual recording errors.
It improves the efficiency and control accuracy of clinical trials, ensures the correct implementation of treatment plans, reduces the number of tasks and error rates of manual recording, and enhances the flexibility and scientificity of the trial.
Smart Images

Figure CN114300156B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of data processing technology, and specifically to a method, device, equipment and storage medium for dispensing drugs to subjects in a clinical trial. Background Art
[0002] Clinical trials are conducted by systematically studying drugs on humans to determine the efficacy and safety of the test drugs. In clinical trials, people who participate in clinical trials are usually called subjects, and subjects can be patients or healthy volunteers. In order to evaluate the comprehensiveness of clinical trials, a large number of subjects and multiple test plans are usually required, so there is a problem of difficulty in implementation. Summary of the invention
[0003] In view of this, multiple embodiments of this specification are dedicated to providing a method, device, equipment and storage medium for dispensing drugs to subjects in a clinical trial, which is conducive to improving the efficiency of clinical trials.
[0004] An embodiment of the present specification provides a method for distributing drugs to subjects in a clinical trial, wherein the clinical trial includes multiple visits arranged in chronological order; drugs are distributed to subjects participating in the clinical trial according to the visits; the method includes: binding a regimen determination task to designated visit data; wherein the regimen determination task is used to determine a treatment regimen for the subject; the designated visit data is used to represent a designated visit among the multiple visits; when the clinical trial is executed to the designated visit, the regimen determination task is triggered; after the regimen determination task is executed, drugs are distributed to the subject according to the treatment regimen determined by the regimen determination task.
[0005] The embodiment of the present specification provides a device for dispensing drugs to subjects of a clinical trial, wherein the clinical trial includes a plurality of visits arranged in chronological order; drugs are dispensed to subjects participating in the clinical trial respectively according to the visits; the device includes: a regimen determination task binding module, used to bind a regimen determination task to designated visit data; wherein the regimen determination task is used to determine a treatment regimen for the subject; the designated visit data is used to represent a designated visit among the plurality of visits; a regimen determination task triggering module, used to trigger the regimen determination task when the clinical trial is executed to the designated visit; and a subject drug dispensing module, used to dispense drugs to the subject according to the treatment regimen determined by the regimen determination task after the regimen determination task is executed.
[0006] An embodiment of the present specification provides a computer device, including a memory and a processor, wherein the memory stores a computer program, and when the processor executes the computer program, the method described in any of the above embodiments is implemented.
[0007] An embodiment of the present specification provides a computer-readable storage medium having computer program instructions stored thereon. When the computer program instructions are executed by a processor, the method described in any of the above embodiments is implemented.
[0008] The method for distributing drugs to subjects in a clinical trial provided in the implementation mode of this specification specifies visit data to be bound to a plan determination task, thereby forming an association relationship between the visit and the plan determination task. When the clinical trial is executed to the specified visit, the plan determination task is triggered; after the plan determination task is executed, drugs are distributed to the subjects in accordance with the treatment plan determined by the plan determination task; not only can the execution of the plan confirmation task be monitored, but also it can be ensured that the plan confirmation task is executed before drugs can be distributed to the subjects in accordance with the treatment plan determined by the plan determination task, thereby ensuring the correctness of task execution, thereby reducing the large amount of tasks and easy errors in manual recording, reducing the difficulty of clinical trials, and facilitating the improvement of clinical trial efficiency. BRIEF DESCRIPTION OF THE DRAWINGS
[0009] Figure 1 Shown is an interactive schematic diagram of a method for dispensing drugs to subjects in a clinical trial in a scenario example provided by one embodiment.
[0010] Figure 2 Shown is a schematic flow chart of a method for dispensing drugs to subjects in a clinical trial provided in one embodiment.
[0011] Figure 3 Shown is a structural block diagram of a device for dispensing drugs to subjects in a clinical trial provided by one embodiment.
[0012] Figure 4 Shown is a diagram of the internal structure of a computer device provided by one embodiment. DETAILED DESCRIPTION
[0013] The following will be combined with the drawings in some of the embodiments of the specification to clearly and completely describe the technical solutions in some of the embodiments of the specification. Obviously, the described embodiments are only some of the embodiments of the specification, not all of the embodiments. Based on the embodiments in this specification, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of this specification.
[0014] See also Figure 1In a specific scenario example, a clinical trial includes multiple visits arranged in chronological order, and multiple visits may correspond to treatment plans. During the clinical trial, the vital signs of the subjects may change. Therefore, adjusting the treatment plan according to the different vital signs of the subjects is conducive to improving the scientific nature of the clinical trial and obtaining multiple groups of controlled trials. For example, a clinical trial may include 30 visits, and a plan determination task can be bound to the 15th visit. Before the start of the 15th visit, the treatment plan of the subject is determined based on the physical examination results of the subject, such as the treatment plan for the 15th visit and thereafter based on the uric acid test results of the subject. Before the execution of the visit binding plan determination task is completed, the subject's treatment plan is not determined, or the subject cannot be given drugs.
[0015] The executing researcher can be a role with the authority to perform the drug dispensing task in the clinical trial. The executing researcher can perform the drug dispensing task through the drug dispensing function of the randomization and drug management system. Specifically, the executing researcher can operate a client (for example, operate a computer), select the visit for which the subject needs to perform the drug dispensing task, click the drug dispensing button, and send a drug dispensing task execution request. In response to sending the drug dispensing task execution request, the server can determine the visit information and subject information pointed to by the drug dispensing task based on the drug dispensing task request. Taking the visit pointed to by the current drug dispensing request as the 15th visit as an example, when the scheme determination task is executed, the treatment scheme of the visit is determined, and the corresponding drug information can be determined.
[0016] There may be a correspondence between the treatment plan and the visit of the subject. The server determines the treatment plan corresponding to the visit based on the visit information. When the binding plan determines that the task is executed, the treatment plan corresponding to the visit is determined, so that the drug specifications can be determined. The correspondence between the drug specifications and the drug identification can be pre-configured. The drug identification can have a distribution status identification. The distribution status identification can include a first value indicating that the drug represented by the drug identification cannot be distributed, and a second value indicating that the drug represented by the drug identification can be distributed. The drug identification can also have a serial number identification, which indicates the number of drugs of the same specification. The drug identification is queried based on the drug specification information, and according to the serial number identification, the drug identification with the distribution status identification of the second value is fed back to the client that sends the drug distribution task execution request, and the distribution status identification of the drug identification can be set to the first value to realize the execution of the drug distribution task.
[0017] See also Figure 2 The present specification provides a method for dispensing drugs to subjects in a clinical trial. The drug dispensing method may include the following steps.
[0018] Step S110: Binding a regimen determination task to designated visit data; wherein the regimen determination task is used to determine a treatment regimen for a subject; and the designated visit data is used to represent a designated visit among the multiple visits.
[0019] In some embodiments, a clinical trial is pre-configured with multiple visits, and each visit is arranged in chronological order. A single visit can last for a certain period of time, for example, the corresponding time of the visit can be one week, or the corresponding time of the visit can be one day. There can be a time interval between two adjacent visits, for example, a clinical trial includes a one-week interval between the adjacent first visit and the second visit; or there is no time interval between multiple visits, for example, the first visit is from January 1 to January 3, and the second visit is from January 4 to January 6.
[0020] In some embodiments, multiple subjects participate in clinical trials, and the treatment plan of the clinical trials can correspond to the visits, and the subjects participate in the execution of the treatment plan corresponding to the visits. The clinical trial can include multiple test groups. When the subjects participate in the clinical trial, the subjects can be randomly enrolled in advance, and the subjects are randomly assigned to a test group. The treatment plans of different test groups can be different. Different treatment plans can refer to different treatment plans under some visits. For example, under the second visit, the treatment plan of the first test group is to take 10 mg of medicine, and the treatment plan of the second test group is to take 20 mg of medicine. The treatment plans of the subjects under the same test group can be the same or different. The different treatment plans of the subjects can be different treatment plans under some visits. When the subject treatment plan is executed to a visit, the multiple subjects participating in the clinical experiment can execute the same treatment plan or different treatment plans. For a single subject, the time of enrollment can be different, and the time of executing the treatment plan corresponding to the visit can be different. In the clinical trial, the treatment plan is executed according to the visit, and the subject is the implementation object of the treatment plan.
[0021] In some embodiments, drugs are dispensed to subjects participating in clinical trials according to visits, and when visits have corresponding treatment plans, drugs to be dispensed to subjects can be determined according to the treatment plans, so that drugs can be dispensed to subjects participating in clinical trials according to visits. The treatment plan can include a medication plan, and the treatment plan can be pre-configured with drug types, drug specifications, and drug quantities. The treatment plan can correspond to the visit, and when the visit is executed, drugs can be dispensed according to the treatment plan corresponding to the visit. Drug types can include test drugs and placebos; drug specifications can include the dosage of each bottle of drugs and the dosage of each box of drugs, such as 50 pills / bottle, 3ml / bottle; the number of drugs can include 1 bottle, 2 boxes, etc. The treatment plan can have a treatment plan identifier for indicating the treatment plan, and the treatment plan can be determined according to the treatment plan identifier. Specifically, the treatment plan configuration information can be queried according to the treatment plan identifier to determine the drug type, drug specifications, drug quantity, and other information. In some embodiments, the treatment plan can include drug specifications and drug quantities, and the drug specifications are, for example, 50 pills / bottle, and the drug quantity is, for example, 1. Different types of drugs may have different drug specifications, and the drug types can be distinguished by drug specifications, so that the drugs can be dispensed to the subjects based on the drug specifications and drug quantities included in the treatment plan.
[0022] In some embodiments, in one visit, different subjects may receive the same medication dispensing task, and different subjects may receive different medication dispensing tasks. The execution of the medication dispensing task may be determined according to the treatment plan. For example, the medication dispensing task may be configured with a mapping relationship with the treatment plan, and the medication dispensing task corresponding to the treatment plan may be determined according to the treatment plan. The medication dispensing task may include providing the subject with a medication of a preset medication specification and a preset medication quantity. The medication dispensing task may include displaying the medication identification corresponding to the treatment plan to the medication dispensing task requester.
[0023] In some embodiments, during a visit, the subject may also need to participate in some examination tasks. The examination tasks include physical examination, routine blood test, routine urine test, etc. The subject may participate in the examination task and receive the medicine issued by the medicine issuing task in the same visit. It is understood that the medicine issued to the subject may be the expected test medicine or a placebo.
[0024] In some embodiments, the treatment plan corresponding to the visit is pre-configured, or multiple treatment plans can be provided for selection. The treatment plan can be determined when the visit is performed or before the visit is performed. After the treatment plan is determined, the medication dispensing task based on the treatment plan can be performed during the visit.
[0025] In some embodiments, the visit data is used to represent a visit, and the visit data can be letters, numbers, etc. There is a corresponding relationship between the visit data and the visit, and the visit can be determined based on the visit data. The designated visit data is used to represent a designated visit among multiple visits, and the designated visit is one of the multiple visits.
[0026] In some embodiments, for multiple visits, a regimen determination task may be set for one or more visits. The regimen determination task is used to determine a treatment regimen for the subject, and the regimen determination task may be to determine a treatment regimen for a designated visit represented by designated visit data, or to determine a treatment regimen for a visit other than the designated visit, for example, to determine a treatment regimen for a visit that is time-sequenced after the designated visit.
[0027] In some embodiments, for multiple subjects, the designated visits may be the same, and the designated visits may be different. Or some subjects have designated visit data for binding scheme determination tasks during the participation in clinical trials, and some subjects do not have designated visit data for binding scheme determination tasks during the participation in clinical trials. It can be that at least one designated visit in the visits corresponding to each subject in the same subject group is bound with a scheme confirmation task, and the designated visits of the subjects in the same subject group can be the same visit. For example, in the same subject group, the 10th visit of each subject is bound with a scheme determination task. Or, for example, in the same subject group, the 10th visit and the 20th visit of each subject are bound with a scheme determination task. It can be that the subjects of some subjects in multiple subject groups have designated visits, and some subject groups do not set scheme determination tasks for visits.
[0028] In some embodiments, the regimen determination task is used to determine a treatment regimen for a subject, and a treatment regimen can be determined for a designated visit or for multiple visits. For example, a designated visit can determine a treatment regimen for a visit that is time-sequenced after the designated visit, and then all visits that are time-sequenced after the designated visit will conduct clinical trials for the subject according to the treatment regimen determined by the designated visit. The regimen determination task is used to determine a treatment regimen for a subject, and one treatment regimen can be determined from multiple treatment regimens. Multiple treatment regimens can be pre-configured treatment regimens. The treatment regimen is determined so that drugs can be dispensed to the subject according to the visit.
[0029] By specifying the task of binding the visit data to the program, the problem of human monitoring prone to errors and low efficiency is solved, which is conducive to improving the control accuracy and efficiency of clinical trials. In addition, the treatment plan of the subjects can be confirmed during the implementation of the clinical trial, which improves the flexibility of the clinical trial.
[0030] Step S120: When the clinical trial is performed to the designated visit, triggering the protocol determination task.
[0031] In some embodiments, the clinical trial is performed until the designated visit, which can be a clinical trial of a subject. The designated visit can be configured to last for a certain period of time, and the clinical trial is performed until the designated visit can be the start time point of the clinical trial, the end time point of the clinical trial, or any time in the duration period of the clinical trial.
[0032] In some embodiments, triggering the scheme determination task may be to generate a scheme confirmation task reminder, and the scheme confirmation task reminder may be sent to a designated role, such as a project manager. Triggering the scheme determination task may be to obtain designated data required for executing the scheme determination task, such as data generated during the implementation of the clinical trial of the subject, and the designated data may be configured with a mapping relationship with the treatment scheme, so that the treatment scheme can be determined based on the designated data.
[0033] In some embodiments, the clinical trial may include multiple treatment stages, and the multiple treatment stages may be arranged in chronological order. For example, the clinical trial includes a first treatment stage and a second treatment stage arranged in chronological order. Multiple visits may belong to different treatment stages, and each treatment stage may include multiple visits. The clinical trial may include multiple subject groups, and the multiple subject groups may have different treatment plans, and the subjects may be in different subject groups. For the same subject group, the treatment plans in the first treatment stage and the second treatment stage may be different. For the same subject group, the treatment plan in the first treatment stage may include at least one, and the treatment plan in the second treatment stage may include at least one. For a subject, the drug dispensing tasks of subjects in different treatment stages may be different, and the drug dispensing tasks of subjects in different visits in the same treatment stage may be the same. The different drug dispensing tasks of the subjects may be different in the types of drugs, or may be different in the dosage of drugs. In some embodiments, the designated visit may be the last visit of the first treatment stage, or the designated visit may be the first visit of the second treatment stage, or may be other visits. It can be understood that the designated visit is no later than the visit corresponding to the treatment plan determined by the plan determination task. In some embodiments, the designated visit may be a visit in the first treatment phase, and the treatment regimen determined by the regimen determination task may be applied to the visit in the second treatment phase. At least some of the subjects may have different treatment regimens in the first treatment phase and the second treatment phase, and different medication dispensing tasks, while some of the subjects may have the same treatment regimens in the first treatment phase and the second treatment phase, and the same medication dispensing tasks.
[0034] The regimen determination task is used to determine the treatment regimen for the subject. The treatment regimen includes the task of dispensing medication. Thus, when the regimen confirmation task bound to the specified visit data is completed, medication can be dispensed to the subject according to the treatment regimen.
[0035] Step S130: After the regimen confirmation task is executed, administer medicine to the subject according to the treatment regimen determined by the regimen determination task.
[0036] In some embodiments, the scheme confirmation task can be executed by selecting one from a plurality of pre-configured treatment schemes. The scheme determination task can be performed manually to reduce the complexity of the system; it can be performed online, for example, the execution logic of the scheme confirmation task can be pre-configured. Specifically, the correspondence between preset data and treatment schemes can be configured. When executing the scheme confirmation task, preset data is obtained, such as clinical trial data generated by subjects participating in clinical trials, and the treatment scheme is obtained according to the clinical trial data values and the pre-configured correspondence. The clinical trial data values in the scheme confirmation process may not be visible to the clinical trial execution researchers, thereby improving the blind control of clinical trials. The executor of the scheme confirmation task may be different from the executor of drug distribution to the subjects. For example, the executor of drug distribution to the subjects may be the executing researcher, and the executor of the scheme confirmation task may be a role other than the executor, thereby avoiding the influence of the subjective factors of the executing researcher on the clinical trial treatment scheme, and improving the scientificity of the clinical trial and the accuracy of blind control.
[0037] In some embodiments, after the regimen determination task is executed, the subject's treatment regimen is determined, which may be a treatment regimen for a designated visit, or a treatment regimen chronologically arranged after the designated visit. The treatment regimen includes a regimen for the subject to take medication, and thus medication may be dispensed to the subject based on the treatment regimen.
[0038] The method for dispensing drugs to subjects in clinical trials provided in the embodiments of this specification can meet the needs of complex clinical trials, confirm treatment plans in clinical trials, and improve the flexibility of clinical trials by binding the specified visit data to the plan determination task. Specifying the visit data to bind the plan determination task forms a strong association between the visit and the plan determination task, which can not only monitor the execution of the plan confirmation task, but also ensure that the plan confirmation task is executed before the drug can be dispensed to the subject in accordance with the treatment plan determined by the plan determination task, ensuring the correctness of task execution, which is conducive to reducing the large amount of tasks and easy errors in manual record confirmation tasks, reducing the difficulty of clinical trials, and helping to improve the efficiency of clinical trials.
[0039] In some embodiments, drugs are dispensed to the subject in accordance with a first treatment plan before the designated visit, and the treatment plan determined by the plan determination task is a second treatment plan; the method further includes: before the designated visit, executing a first drug dispensing task included in the first treatment plan; wherein the first drug dispensing task corresponds to a first drug identifier, and the first drug dispensing task is used to instruct the dispensing of the drug represented by the first drug identifier; after the designated visit, executing a second drug dispensing task included in the second treatment plan; wherein the second drug dispensing task corresponds to a second drug identifier, and the second drug dispensing task is used to instruct the dispensing of the drug represented by the second drug identifier.
[0040] In some embodiments, before the designated visit, the drug is dispensed to the subject in accordance with the first treatment plan, and the first treatment plan includes a first drug dispensing task. Then, before the designated visit, the drug is dispensed to the subject by executing the first drug dispensing task. The first drug dispensing task corresponds to a first drug identifier, and the first drug dispensing task is used to instruct the dispensing of the drug indicated by the first drug identifier, thereby dispensing the drug matching the first treatment plan. When the visit corresponding to the first treatment plan includes the designated visit, the first treatment plan is executed under the designated visit.
[0041] In some embodiments, after the designated visit, if the visit corresponding to the second treatment plan includes the designated visit, the designated visit executes the second treatment plan; the visit corresponding to the second treatment plan may include some or all visits arranged in chronological order after the designated visit, and the corresponding visit may execute the second medication dispensing task included in the second treatment plan. The second medication dispensing task corresponds to a second medication identifier, and the second medication dispensing task is used to instruct the dispensing of the medication indicated by the second medication identifier, thereby achieving medication dispensing matching the second treatment plan.
[0042] In some embodiments, a designated visit can dispense medication to a subject according to a first treatment regimen, and a visit chronologically arranged after the designated visit can perform a second medication dispensing task included in the second treatment regimen. In some embodiments, a designated visit can dispense medication to a subject according to a first treatment regimen, and a visit chronologically arranged before the designated visit can dispense medication to a subject according to the first treatment regimen, and the designated visit and the visit chronologically arranged after the designated visit can perform a second medication dispensing task included in the second treatment regimen.
[0043] In some embodiments, the second treatment regimen may be the same as the first treatment regimen, or the second treatment regimen may be different from the first treatment regimen. Regardless of whether the second treatment regimen is the same as the first treatment regimen, the first drug identifier and the second drug identifier are different.
[0044] The drug dispensing task is associated with the treatment plan, which improves the safety of clinical trials. After binding the designated visit confirmation plan, the second drug dispensing task included in the second treatment plan is executed, which improves the management and control of clinical trials.
[0045] In some embodiments, before the designated visit, the step of executing the first medication dispensing task included in the first treatment plan includes: receiving a first medication dispensing task execution request, the first medication dispensing task execution request carrying a first treatment plan identifier pointing to the first treatment plan; the first treatment plan is configured with a preset drug specification and a preset drug quantity; querying a first drug identifier set according to the preset drug specification and the preset drug quantity; the first drug identifier set includes a plurality of different first drug identifiers, and the drugs represented by the plurality of different first drug identifiers have the same preset drug specification; and dispensing a preset quantity of drugs represented by the preset drug quantity to the subject according to the first drug identifier.
[0046] In some embodiments, the first medication dispensing task execution request carries a first treatment scheme identifier pointing to the first treatment scheme, so that the first treatment scheme can be determined according to the medication dispensing task request. The first treatment scheme is configured with preset drug specifications and preset drug quantities, and the drug specifications and drug quantities can be obtained by querying the configuration information. For example, if the treatment scheme is scheme A, the drug specifications are 100 pills / box, and the drug quantity is 1, then a corresponding relationship between treatment scheme A and the rule 100 pills / box and quantity 1 can be pre-configured. When the medication dispensing task execution request carries a scheme identifier pointing to treatment scheme A, it can be determined according to the medication dispensing task execution that a drug dispensing task with a specification of 1 and a rule of 100 pills / box needs to be issued to the subject. Therefore, the first treatment scheme configuration can be queried based on the first treatment scheme identifier carried by the first medication dispensing task execution request to determine the preset drug specifications and preset drug quantities of the first treatment scheme.
[0047] In some embodiments, the first drug identification set includes a plurality of different first drug identifications, and the drugs represented by the first drug identifications have the same preset drug specifications. The first drug identification may have drug specification information, and the drug specification information is the preset drug specification. It is understood that the drug specifications of the drugs represented by the plurality of first drug identifications in the first drug identification set match the preset drug specifications configured for the first treatment regimen, so that the drug that complies with the first treatment regimen can be dispensed to the subject.
[0048] In some embodiments, a preset number of drugs represented by a preset drug quantity is dispensed to the subject according to the drug identifier. For example, if the preset drug quantity is 2, the drug dispensing task requires dispensing 2 drugs with preset drug rules to the subject, and the 2 preset drug specifications of the drugs are determined based on the first drug identifier.
[0049] In some embodiments, before the designated visit, the step of executing the first medication dispensing task included in the first treatment plan includes: receiving a first medication dispensing task execution request, the first medication dispensing task execution request carrying a first treatment plan identifier pointing to the first treatment plan; the first treatment plan is configured with a preset drug type, a preset drug specification, and a preset drug quantity; querying a first drug identifier set according to the preset drug type, the preset drug specification, and the preset drug quantity; the first drug identifier set includes a plurality of different first drug identifiers, and the drugs represented by the plurality of different first drug identifiers have the same preset drug type and preset drug specification; and dispensing a preset quantity of drugs represented by the preset drug quantity to the subject according to the first drug identifier.
[0050] In some embodiments, the first drug identifier has a dispensing status identifier, and the dispensing status identifier includes a first value indicating that the drug represented by the first drug identifier cannot be dispensed; in the first treatment period, the first drug dispensing task step included in the first treatment plan includes: setting the dispensing status identifier of the first drug identifier to the first value. It can be understood that each first drug identifier can have a dispensing status identifier, and the dispensing status identifier can include a first value indicating that the drug represented by the first drug identifier cannot be dispensed, and can include a second value indicating that the drug represented by the first drug identifier can be dispensed. Before the drug dispensing task is executed, the drug dispensing status identifier can be the second value, and executing the drug dispensing task can be to set the drug identifier to the first value. Thereby avoiding repeated dispensing or dispensing failure in subsequent dispensing tasks.
[0051] In some embodiments, before the designated visit, the step of executing the first medication dispensing task included in the first treatment plan includes: receiving a first medication dispensing task execution request, the first medication dispensing task execution request carrying a first identifier pointing to the first visit; determining the first medication identifier according to the first identifier; wherein the first identifier and the first medication identifier are configured with a mapping relationship; and dispensing medication to the subject according to the first medication identifier. By configuring a mapping relationship between the first identifier and the first medication identifier, or in other words, the first identifier and the first medication identifier correspond one-to-one, when the first medication dispensing task execution request carries the first identifier pointing to the first visit, the first medication identifier can be determined based on the first representation, thereby dispensing the medication pointed to by the first medication identifier to the subject.
[0052] In some embodiments, the method further includes: receiving a first medication dispensing task execution request, the first medication dispensing task execution request corresponds to a first requesting party; accordingly, the first medication dispensing task is used to provide the first medication identification to the first requesting party. The first medication dispensing task execution request may carry an identification pointing to the first requesting party. The first medication dispensing task execution request may be initiated by an executing researcher. The first medication dispensing task is used to provide the first medication identification to the first requesting party, which may be to display the first medication identification to the first requesting party. For example, the first medication dispensing task execution request may be initiated by an executing researcher, and accordingly, the first medication identification is provided to the executing researcher, thereby indicating that the medication represented by the first medication identification can be distributed to the subject. The first medication identification may also be provided to a medication administrator or other non-first requesting party role, and the medication administrator may transfer the medication based on the medication identification after receiving the first medication identification, such as removing the medication from storage.
[0053] In some embodiments, the second treatment plan corresponds to an implementation visit, the implementation visit is configured with multiple preset treatment plans, the preset plan has a preset plan identifier, and the second treatment plan has a second treatment plan identifier; the method also includes: when the second treatment plan identifier matches the preset plan identifier, the second medication dispensing task is started. The second treatment plan identifier matches the preset plan identifier, which can be that the second treatment plan identifier is the same as one of the multiple preset plan identifiers. The execution of the plan confirmation task can be to finally determine a treatment plan from multiple preset treatment plans to form a second treatment plan. The execution of the plan confirmation task can be to select a treatment plan from a set of treatment plans, and the treatment plan set can include multiple preset treatment plans configured for the implementation visit, and can also include other treatment plans. This plan can eliminate the need for judgment when executing the plan confirmation task, reduce the complexity of the plan, support human-selected verification, and support a variety of application scenarios.
[0054] In some embodiments, the method further includes: obtaining an execution record of the scheme determination task; accordingly, after the scheme confirmation task is executed, dispensing medicine to the subject in accordance with the treatment scheme determined by the scheme determination task, including: dispensing medicine to the subject in accordance with the treatment scheme determined by the scheme determination task only when the execution record indicates that the scheme determination task is successfully executed. In some embodiments, obtaining the execution record of the scheme determination task indicates that the scheme determination task is successfully executed. The execution record of the scheme determination task may include treatment scheme information, and the execution record may indicate that the scheme determination task is successfully executed when the treatment scheme information is recorded.
[0055] In some embodiments, the regimen determination task is used to determine a treatment regimen for a preset visit for a subject, the preset visit is configured with multiple default treatment regimens, the default treatment regimen has a default regimen identifier, and preset medical matter data is obtained, the preset medical matter data is based on clinical trial data generated by visits before the preset visit that are arranged in chronological order of the subject's participation; the preset treatment regimen represented by the default regimen identifier that matches the preset medical matter data is selected as the treatment regimen determined by the regimen determination task.
[0056] In some embodiments, the regimen determination task is used to determine a treatment regimen for a subject for a preset visit, which may be a single visit or multiple visits. The preset visit may include a designated visit, or may be a visit that is chronologically arranged after the designated visit, or may include a visit that is chronologically arranged after the designated visit.
[0057] In some embodiments, the default treatment regimen may include a preset treatment regimen, or the default treatment regimen may be a preset treatment regimen.
[0058] In some embodiments, a preset visit is configured with a plurality of default treatment plans, the default treatment plan having a default treatment plan identifier, and the default treatment plan can be used for the treatment plan determined by the treatment plan determination task.
[0059] In some embodiments, the preset medical matter data is data generated by the subject's participation in a clinical trial, and specifically can be clinical trial data generated by a visit that the subject participated in chronologically before the preset visit; thus, the subject's clinical trial data can be used as a basis for determining a treatment plan. The preset medical matter data can be, for example, the number of visits in which the subject participated, or can be the value of an indicator in the subject's physical examination results. The mapping relationship between the preset medical matter data and the default treatment plan can be pre-configured, so that the preset treatment plan represented by the default plan identifier that matches the preset medical matter data is used as the treatment plan determined by the plan determination task.
[0060] See also Figure 3. An embodiment of the present specification provides a device for dispensing drugs to subjects in a clinical trial. In some embodiments, the clinical trial includes multiple visits arranged in chronological order; drugs are dispensed to subjects participating in the clinical trial according to the visits respectively; the device may include: a regimen determination task binding module, used to bind a regimen determination task to a specified visit data; wherein the regimen determination task is used to determine a treatment regimen for the subject; the specified visit data is used to represent a specified visit among the multiple visits; a regimen determination task triggering module, used to trigger the regimen determination task when the clinical trial is executed to the specified visit; a subject drug dispensing module, which, after the regimen determination task is executed, dispenses drugs to the subject according to the treatment regimen determined by the regimen determination task.
[0061] For the specific definition of the drug dispensing device for subjects in clinical trials, please refer to the definition of the drug dispensing device method for subjects in clinical trials above, which will not be repeated here. The various modules in the drug dispensing device for subjects in the above clinical trials can be implemented in whole or in part by software, hardware and a combination thereof. The above modules can be embedded in or independent of the processor in the computer device in the form of hardware, or can be stored in the memory of the computer device in the form of software, so that the processor can call and execute the operations corresponding to the above modules.
[0062] See also Figure 4 . In some embodiments, a computer device is provided, which may be a terminal. The computer device includes a processor, a memory, a communication interface, a display screen, and an input device connected via a system bus. Among them, the processor of the computer device is used to provide computing and control capabilities. The memory of the computer device includes a non-volatile storage medium and an internal memory. The non-volatile storage medium stores an operating system and a computer program. The internal memory provides an environment for the operation of the operating system and the computer program in the non-volatile storage medium. The communication interface of the computer device is used to communicate with an external terminal in a wired or wireless manner, and the wireless manner can be achieved through WIFI, an operator network, NFC (near field communication) or other technologies. When the computer program is executed by the processor, a clinical trial data conversion method is implemented. The display screen of the computer device may be a liquid crystal display screen or an electronic ink display screen, and the input device of the computer device may be a touch layer covering the display screen, or a button, a trackball or a touchpad provided on the housing of the computer device, or an external keyboard, touchpad or mouse, etc.
[0063] Those skilled in the art will understand that Figure 4The structure shown in the figure is only a block diagram of a part of the structure related to the implementation mode of this specification, and does not constitute a limitation on the computer device to which the implementation mode of this specification is applied. The specific computer device may include more or fewer components than shown in the figure, or combine certain components, or have a different component arrangement.
[0064] In some embodiments, a computer device is provided, including a memory and a processor, wherein a computer program is stored in the memory, and the method in the above embodiment is implemented when the processor executes the computer program.
[0065] In some embodiments, a computer-readable storage medium is provided, on which a computer program is stored. When the computer program is executed by a processor, the method in the above embodiment is implemented.
[0066] Those of ordinary skill in the art can understand that all or part of the processes in the above-mentioned implementation methods can be completed by instructing the relevant hardware through a computer program, and the computer program can be stored in a non-volatile computer-readable storage medium. When the computer program is executed, it can include the processes of the implementation methods of the above-mentioned methods. Among them, any reference to memory, storage, database or other media used in the implementation methods of this specification may include at least one of non-volatile and volatile memory. Non-volatile memory may include read-only memory (ROM), magnetic tape, floppy disk, flash memory or optical memory, etc. Volatile memory may include random access memory (RAM) or external cache memory. As an illustration and not limitation, RAM can be in various forms, such as static random access memory (SRAM) or dynamic random access memory (DRAM).
[0067] The multiple embodiments in this specification emphasize the parts that are different from other embodiments, and the various embodiments can be explained in comparison with each other. Any combination of the multiple embodiments in this specification by technicians in the relevant field based on general technical knowledge is included in the disclosure scope of this specification.
[0068] The technical features of the above embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.
[0069] The above descriptions are only some of the implementation methods in this specification and are not intended to limit this specification. Any modifications, equivalent substitutions, etc. made within the spirit and principles of this specification should be included in the scope of disclosure of this specification.
Claims
1. A method for dispensing drugs to subjects in a clinical trial, characterized in that: The clinical trial includes multiple visits arranged in chronological order; drugs are dispensed to subjects participating in the clinical trial according to the visits; wherein drugs are dispensed to the subjects according to a first treatment regimen before a designated visit among the multiple visits; the method includes: Binding a scheme determination task to the designated visit data; wherein the scheme determination task is used to determine a treatment scheme for the subject; the treatment scheme determined by the scheme determination task is a second treatment scheme; the second treatment scheme corresponds to an implementation visit, the implementation visit is configured with a plurality of preset treatment schemes, the preset treatment scheme has a preset scheme identifier, and the second treatment scheme has a second treatment scheme identifier; the designated visit data is used to represent the designated visit; Before the designated visit, executing a first medication dispensing task included in the first treatment plan; wherein the first medication dispensing task corresponds to a first medication identifier, and the first medication dispensing task is used to instruct dispensing the medication indicated by the first medication identifier; When the clinical trial is executed to the designated visit, the regimen determination task is triggered; after the regimen determination task is executed, the medicine is dispensed to the subject in accordance with the treatment regimen determined by the regimen determination task; including: after the designated visit, and when the second treatment regimen identifier matches the preset regimen identifier, executing the second medicine dispensing task included in the second treatment regimen; wherein the second medicine dispensing task corresponds to a second medicine identifier, and the second medicine dispensing task is used to instruct the dispensing of the medicine represented by the second medicine identifier.
2. The method according to claim 1, characterized in that Before the designated visit, the step of executing the first medication dispensing task included in the first treatment plan comprises: receiving a first medication dispensing task execution request, wherein the first medication dispensing task execution request carries a first treatment plan identifier pointing to the first treatment plan; the first treatment plan is configured with a preset medication specification and a preset medication quantity; According to the preset drug specification and the preset drug quantity, a first drug identification set is searched; the first drug identification set includes a plurality of different first drug identifications, and the drugs represented by the plurality of different first drug identifications have the same preset drug specification; A preset amount of medicine represented by the preset medicine quantity is dispensed to the subject according to the first medicine identifier.
3. The method according to claim 1, characterized in that Before the designated visit, the step of executing the first medication dispensing task included in the first treatment plan comprises: receiving a first medication dispensing task execution request, wherein the first medication dispensing task execution request carries a first identifier pointing to a first visit corresponding to a first treatment plan; Determine the first drug identifier according to the first identifier; wherein a mapping relationship is configured between the first identifier and the first drug identifier; Dispense medicine to the subject according to the first medicine identification.
4. The method according to claim 2 or 3, characterized in that: The first drug identifier has a dispensing status identifier, and the dispensing status identifier includes a first value indicating that the drug represented by the first drug identifier cannot be dispensed; in the first treatment period, the first drug dispensing task step included in the first treatment plan includes: The dispensing status identifier of the first drug identifier is set to the first value.
5. The method according to claim 1, characterized in that: The method further comprises: receiving a first medication dispensing task execution request, wherein the first medication dispensing task execution request corresponds to a first requesting party; Correspondingly, the first drug dispensing task is used to provide the first drug identification to the first requesting party.
6. The method according to claim 1, characterized in that The method further comprises: Obtaining execution records of tasks determined by the scheme; Accordingly, after the regimen confirmation task is executed, dispensing medicine to the subject according to the treatment regimen determined by the regimen determination task includes: Only when the execution record indicates that the regimen determination task is successfully executed, the drug is dispensed to the subject according to the treatment regimen determined by the regimen determination task.
7. The method according to claim 1, characterized in that The scheme determination task is used to determine a treatment scheme for a preset visit for a subject, wherein the preset visit is configured with a plurality of default treatment schemes, and the default treatment scheme has a default scheme identifier. The method further includes: Acquire preset medical event data, wherein the preset medical event data is based on clinical trial data generated by visits prior to the preset visit in chronological order of the subject's participation; The default treatment plan indicated by the default plan identifier that matches the preset medical matter data is selected as the treatment plan determined by the plan determination task.
8. A drug dispensing device for clinical trial subjects, characterized in that: The clinical trial comprises a plurality of visits arranged in chronological order; drugs are dispensed to subjects participating in the clinical trial respectively according to the visits; wherein drugs are dispensed to the subjects according to a first treatment regimen before a designated visit among the plurality of visits; the device comprises: A scheme determination task binding module is used to bind a scheme determination task to the specified visit data; wherein the scheme determination task is used to determine a treatment plan for the subject; the treatment plan determined by the scheme determination task is a second treatment plan; the second treatment plan corresponds to an implementation visit, the implementation visit is configured with multiple preset treatment plans, the preset treatment plan has a preset plan identifier, and the second treatment plan has a second treatment plan identifier; the specified visit data is used to represent a specified visit among the multiple visits; a scheme determination task triggering module, configured to trigger the scheme determination task when the clinical trial is performed to the designated visit; and to execute the first drug dispensing task included in the first treatment scheme before the designated visit; wherein the first drug dispensing task corresponds to a first drug identifier, and the first drug dispensing task is used to instruct the dispensing of the drug indicated by the first drug identifier; A subject drug dispensing module is used to dispense drugs to the subject in accordance with the treatment plan determined by the plan determination task after the plan determination task is executed; wherein, after the designated visit, and when the second treatment plan identifier matches the preset plan identifier, a second drug dispensing task included in the second treatment plan is executed; wherein the second drug dispensing task corresponds to a second drug identifier, and the second drug dispensing task is used to instruct the dispensing of the drug represented by the second drug identifier.
9. A computer device comprising a memory and a processor, wherein the memory stores a computer program, wherein: When the processor executes the computer program, the method according to any one of claims 1 to 7 is implemented.
10. A computer-readable storage medium having computer program instructions stored thereon, characterized in that: When the computer program instructions are executed by a processor, the method according to any one of claims 1 to 7 is implemented.
